Gazyva Infusion Reaction Investigation

计划入组 104 人 · 首次发布于 2018 年 5 月 18 日

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia

计划入组 110 人 · 首次发布于 2023 年 8 月 16 日

Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma

计划入组 89 人 · 首次发布于 2017 年 11 月 14 日

Epothilone (Azaya Therapeutics)

Liposomal docetaxel (Azaya Therapeutics)

Azaya Therapeutics, Inc.

United States

Lenalidomide and Obinutuzumab Combination Shows Promise in Relapsed Non-Hodgkin Lymphoma

Genentech's Gazyva Demonstrates Efficacy in Phase 3 Lupus Nephritis Trial

FDA Approves Roche's Gazyva for Lupus Nephritis Treatment, Expanding Therapeutic Options